GlassScriptPhysician profile
Sarah E Geyer
NPI 1528698081
$1,444.17
in general payments reported to CMS, 2019-2025
12 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $276 · 2022: $553 · 2023: $318 · 2024: $186 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.87 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,042.17 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $115.32 | 2024 | Austedo Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $79.32 | 2022-2023 | |
| Alkermes, INC. | $65.49 | 2025 | Aristada, Lybalvi |
| Janssen Pharmaceuticals, INC | $30.51 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $23.51 | 2025 | Abilify Asimtufii |
| Sage Therapeutics, LLC | $21.76 | 2023 | |
| Avadel Cns Pharmaceuticals, LLC | $19.17 | 2025 | Lumryz |
| Noven Therapeutics, LLC | $16.64 | 2024 | Xelstrym |
| E.R. Squibb & Sons, L.L.C. | $14.04 | 2024 | |
| Almatica Pharma LLC | $13.22 | 2023 | Loreev Xr |
| Corium, LLC | $3.02 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Geyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.